EverImmune

Recent Finacing

Equity

Recent Raise

$3.7M

EverImmune is a biotechnology company that develops drugs to enhance the effectiveness of immunotherapy treatment in cancer patients, with a current focus on a clinical trial for its drug candidate OncobaxAK.